In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: Interpretive criteria and quality control limits

被引:17
作者
Barry, AL
Fuchs, PC
Allen, SD
Brown, SD
Jorgensen, JH
Tenover, FC
机构
[1] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46202
[2] ST VINCENTS MED CTR,PORTLAND,OR 97225
[3] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[4] CTR DIS CONTROL & PREVENT,ATLANTA,GA 30333
关键词
D O I
10.1093/jac/37.2.365
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The 1-isomer of ofloxacin (levofloxacin) was twice as active as ofloxacin and the d-isomer was inactive against 654 Streptococcus pneumoniae isolates. For disc susceptibility tests of pneumococci, 5 mu g levofloxacin discs can be used with interpretive criteria of less than or equal to 12 mm for resistant (MIC greater than or equal to 8.0 mg/L) and greater than or equal to 16 mm for susceptible (MIC less than or equal to 2.0 mg/L). For quality control of levofloxacin tests, S. pneumoniae ATCC 49619 should give zones 20-25 mm in diameter and MICs 0.5-2.0 mg/L.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 9 条
[1]  
[Anonymous], 1993, M7A3 NCCLS
[2]   A COMPARISON OF ANTIMICROBIAL ACTIVITY OF OFLOXACIN, L-OFLOXACIN, AND OTHER ORAL-AGENTS FOR RESPIRATORY PATHOGENS [J].
CHERUBIN, CE ;
ENG, RHK ;
SMITH, SM ;
TAN, EN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (02) :141-144
[3]  
COOPER B, 1989, AM J MED, V87, P475
[4]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF LEVOFLOXACIN (L-OFLOXACIN), AN OPTICALLY-ACTIVE OFLOXACIN [J].
FU, KP ;
LAFREDO, SC ;
FOLENO, B ;
ISAACSON, DM ;
BARRETT, JF ;
TOBIA, AJ ;
ROSENTHALE, ME .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :860-866
[5]  
PEREZTRALLERO E, 1990, EUR J CLIN MICROBIOL, V9, P905
[6]   LEVOFLOXACIN DISK POTENCY AND TENTATIVE INTERPRETIVE CRITERIA FOR SUSCEPTIBILITY TESTS [J].
PFALLER, MA ;
BARRY, AL ;
FUCHS, PC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) :1924-1926
[7]   PNEUMOCOCCAL MENINGITIS DURING INTRAVENOUS CIPROFLOXACIN THERAPY [J].
RIGHTER, J .
AMERICAN JOURNAL OF MEDICINE, 1990, 88 (05) :548-548
[8]   SUGGESTED MODIFICATIONS FOR DISK DIFFUSION SUSCEPTIBILITY TESTING CRITERIA FOR LEVOFLOXACIN AND SPARFLOXACIN FOLLOWING TESTS WITH A PREDICTOR PANEL OF CIPROFLOXACIN-RESISTANT CLINICAL ISOLATES [J].
SUTTON, LD ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :146-148
[9]  
1993, M2A5 NCCLS